Drug Candidate
PMI03
Summary
Potential first-in-class imaging agent for neuroinflammation/neurodegenerative diseases
Mechanism of Action
PET ligand targeting sEH
Indication
PD, AD, Neuroinflammation
Development Stage
Phase I
PMI03
PMI03
Potential first-in-class imaging agent for neuroinflammation/neurodegenerative diseases
PET ligand targeting sEH
PD, AD, Neuroinflammation
Phase I